AtlanChim Pharma

AtlanChim Pharma serves as a critical contract research and manufacturing organization (CRAMO) for the life sciences industry, offering custom chemical synthesis, analytical services, and impurity isolation. The company leverages deep expertise in organic chemistry, including steroid chemistry and labeled molecules, to support clients' R&D programs from concept to small-scale production. Its strategic focus is on providing tailored solutions and scientific collaboration, as evidenced by its participation in industry events like BIO-EUROPE Spring. However, the company has announced it is now permanently closed, indicating a cessation of operations.

A service-based platform offering custom chemical synthesis, stable isotope labeling (cold labeling), and impurity isolation/structural elucidation for research and development clients.

Total raised: $3M

Competed in the fragmented chemistry CRO/CDMO space against large players like Lonza and Catalent (offering full-service integration) and numerous small, specialized synthetic labs. Differentiation was based on specific expertise in complex molecule synthesis (e.g., steroids, labeled compounds) and personalized service for small-scale, complex projects.